Protective Effects of MK-801 on Apoptosis in Immature Rats With Traumatic Brain Injury

Area of Science:

• Neuroscience
• Cell Biology
• Pharmacology

Background:

• Traumatic brain injury (TBI) is a significant cause of childhood morbidity and mortality.
• Understanding the mechanisms of TBI-induced neuronal damage is crucial for developing effective treatments.

Purpose of the Study:

• To evaluate the neuroprotective effects of MK-801, a noncompetitive NMDA receptor antagonist, on hippocampal damage in young rats following TBI.
• To assess the impact of MK-801 on apoptotic markers in the hippocampus after contusion injury.

Main Methods:

• Wistar Albino rats were divided into control, TBI, and MK-801 treatment groups.
• MK-801 (1 mg/kg) was administered intraperitoneally immediately after TBI induction.
• Apoptotic damage was assessed by measuring immunoreactivity for BAX, cytochrome c, and caspase-3 in the hippocampus.

Main Results:

• TBI significantly increased BAX and cytochrome c immunoreactivity in the hippocampus compared to controls.
• MK-801 treatment markedly reduced BAX and cytochrome c immunoreactivity in TBI rats.
• Caspase-3 immunoreactivity was intense in TBI rats but significantly reduced in the MK-801 group.

Conclusions:

• MK-801 significantly reduces hippocampal apoptosis following TBI in young rats.
• The drug downregulates key pro-apoptotic markers: BAX, cytochrome c, and caspase-3.
• MK-801 demonstrates neuroprotective potential by interfering with the intrinsic apoptotic pathway after TBI.